Review On Recent Advances In Nanomedicine Treatment Of Liver Cirrhosis

Authors

  • Nidhi Sharma , Dr Sandip Prasad Tiwari

DOI:

https://doi.org/10.47750/pnr.2022.13.S10.645

Abstract

Liver failure, liver cirrhosis and liver cancer can all result from liver fibrosis a reversible pathological process of inflammation and fibre deposition brought on by chronic liver injury nanomedicine, a branch of nanotechnology used in medicine holds promise for the detection and treatment of liver fibrosis. Nanomedicine a branch of nanotechnology used in medicine for the treatment of liver fibrosis the time these nanomedicine system improvement techniques. Newly advance technique of nanomedicine is study. For the delivery of various therapeutic agents such as anti-HCV, diagnostic, deal of attention. Viral hepatitis c: - infection HCV was non-A, non-B hepatitis of liver cancer and cirrhosis spherical HCV virus and in a fatty envelope. Different HCV genotypes evolve as result of alteration, mutation of sections of HCV RNA.

Downloads

Published

2022-12-31 — Updated on 2022-12-31

Issue

Section

Articles

How to Cite

Review On Recent Advances In Nanomedicine Treatment Of Liver Cirrhosis. (2022). Journal of Pharmaceutical Negative Results, 5317-5322. https://doi.org/10.47750/pnr.2022.13.S10.645